Prestige Consumer Healthcare to Acquire Breathe Right Nasal Strips Portfolio for $1.045 Billion

March 23, 2026

Prestige Consumer Healthcare entered into a definitive agreement to acquire the Breathe Right nasal strip brand and an accompanying portfolio of OTC brands from Foundation Consumer Healthcare in a $1.045 billion cash transaction (about $900 million net of anticipated tax benefits). The acquired portfolio is expected to generate approximately $200 million in revenue and $95 million in EBITDA (LTM ended December 31, 2025), and the deal is expected to close in the first half of fiscal 2027.

Buyers
Prestige Consumer Healthcare Inc.
Targets
Breathe Right, Dimetapp, Anbesol
Sellers
Foundation Consumer Healthcare
Location
New York, United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Build a buyer list for your deal

Find active buyers from recent acquisition patterns and move straight into outreach.